Evidence map›Paper›PMID 19233742›Full record

ReviewDNA repair2009

Genome stability roles of SUMO-targeted ubiquitin ligases.

J Heideker, J J P Perry, M N Boddy

Open access · greenAbstract readReview
In one paragraph

Review in DNA repair, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. SUMO Chains Rule on Chromatin Occupancy.Frontiers in cell and developmental biology · 2019
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Role of RNF4 in the ubiquitination of Rta of Epstein-Barr virus.The Journal of biological chemistry · 2013
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

J HeidekerDepartment of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
J J P Perry
M N Boddy
Scripps Research Institute · US

Funding

Studies of the Rad60-Smc5-Smc6 DNA Repair ComplexR01GM068608 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI BODDY, MICHAEL N · 2003 to 2020
$6.2M
SUMO-dependent Regulation of Ubiquitin Ligases in Genomic StabilityR01GM081840 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI BODDY, MICHAEL N · 2009 to 2018
$3.0M
Structural Biochemistry of RecQ Helicase InteractionsR01CA104660 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI TAINER, JOHN A. · 2004 to 2008
$1.6M
NCI NIH HHS CA104660NCI NIH HHS R01 CA104660NIGMS NIH HHS GM068608NIGMS NIH HHS GM081840NIGMS NIH HHS R01 GM068608NIGMS NIH HHS R01 GM081840
6 · The paper itself

Abstract

Post-translational modification of the cell's proteome by ubiquitin and ubiquitin-like proteins provides dynamic functional regulation. Ubiquitin and SUMO are well-studied post-translational modifiers that typically impart distinct effects on their targets. The recent discovery that modification by SUMO can target proteins for ubiquitination and proteasomal degradation sets a new paradigm in the field, and offers insights into the roles of SUMO and ubiquitin in genome stability.

Indexed as

Genomic InstabilityAnimalsDNADNA RepairDNA Repair EnzymesDNA ReplicationHumansMAP Kinase Signaling SystemProtein Processing, Post-TranslationalSmall Ubiquitin-Related Modifier ProteinsTranscription, GeneticUbiquitinUbiquitinationUbiquitin-Protein LigasesDNADNA Repair EnzymesSmall Ubiquitin-Related Modifier ProteinsUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID19233742
PMCPMC2685196
OpenAlexW2131663344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.